The N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) mouse model mimics human muscle-invasive bladder cancer (MIBC) at a molecular and a mutational level, according to a new paper. Fantini and co-workers found that BBN tumours showed overexpression of basal cancer subtype markers and a high mutational burden with frequent mutations in Trp53, Kmt2d, and Kmt2c, similar to human MIBC. They say that their findings provide a strong rationale for using the BBN mouse model in molecular and drug discovery studies.